Latvia - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Latvia Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes rose 8.8% year on year. In 2019, the country was number 27 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €94.33 Per Capita. Latvia is overtaken by Estonia, which was ranked number 26 at €118.49 Per Capita and is followed by Lithuania with €91.65 Per Capita. Switzerland topped the ranking with €666.37 Per Capita in 2019, an increase of 3.2% compared to 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania was the worst growing country at -1.7% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 94.33 |
2018 | 95.20 |
2017 | 83.07 |
2016 | 79.04 |
2015 | 66.52 |
How does Latvia rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
# | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
26 |
#26
Estonia
|
118.49 | 2019 | +3.3 % | +5.4 % | View data | |
27 |
#27
Latvia
|
94.33 | 2019 | -0.9 % | +8.8 % | View data | |
28 |
#28
Lithuania
|
91.65 | 2019 | +0.8 % | +5.4 % | View data |